https://www.selleckchem.com/pr....oducts/itacitinib-in
83; 95%CI 0.72-0.95) and, in the 30 days before death, at least one SNH stay (aOR 0.52; 95%CI 0.36-0.76), ICU stay (aOR 0.36; 95%CI 0.30-0.43), inpatient chemotherapy (aOR 0.55; 95%CI 0.48-0.63), outpatient chemotherapy (aOR 0.60; 95%CI 0.51-0.7, death in Rehab (aOR 1.4; 95%CI 1.05-1.86) or HAH (aOR 4.5; 95%CI 2.47-8.1) vs SSH. Overall mean expenditure reimbursed per woman was €38,734 and €42,209 for those with PC. Women with inpatient or outpatient chemotherapy during the last month had lower rates of HPC, suggesting dec
Like
Comment
Share
